Claire Keene is a South African clinician with experience managing a large HIV and tuberculosis project for Médecins Sans Frontières in Khayelitsha, where she also managed the project’s initial COVID-19 response in 2020 and co-led the ARTIST trial, which showed that it is safe to recycle the tenofovir backbone in viraemic HIV patients switching to dolutegravir.

Claire is completing her PhD at the University of Oxford as part of the Health Systems Collaborative – a group conducting health systems research in resource-limited settings. She is using routine healthcare data to examine patterns of patient engagement behaviour over time, in order to apply the concepts of precision public health to HIV service-delivery in South Africa.